A Study to Explore the Effect of Sepranolone in Tourette Syndrome

Clinical trial NCT05434546 · COMPLETED

Trial details

NCT number: NCT05434546
Sponsor: Asarina Pharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Tourette Syndrome Tourette Syndrome in Adolescence

Start date: 2022-02-16
Primary completion: 2023-02-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.